Applied DNA Sciences, Inc.Applied DNA Sciences, Inc.Applied DNA Sciences, Inc.

Applied DNA Sciences, Inc.

No trades
See on Supercharts
Market capitalization
‪6.12 M‬USD
−0.5495USD
‪−9.95 M‬USD
‪13.37 M‬USD
‪14.89 M‬
Beta (1Y)
1.12

About Applied DNA Sciences, Inc.

CEO
James A. Hayward
Website
Headquarters
Stony Brook
Employees (FY)
55
Founded
1983
ISIN
US03815U3005
FIGI
BBG000DGRCY6
Applied DNA Sciences, Inc. engages in developing and marketing technologies to produce and detect deoxyribonucleic acid. It operates through the following segments: Therapeutic DNA Production, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production segment offers DNA detection via PCR to provide and develop clinical molecular diagnostics and genetic testing services. The MDx Testing Services segment is involved in performing and developing clinical molecular diagnostic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment includes manufacture and detection of DNA for industrial supply chain security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of APDN is 0.35 USD — it has decreased by 2.80% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Applied DNA Sciences, Inc. stocks are traded under the ticker APDN.
Applied DNA Sciences, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Applied DNA Sciences, Inc. has a max estimate of 3.00 USD and a min estimate of 1.50 USD.
APDN earnings for the last quarter are −0.26 USD whereas the estimation was −0.27 USD which accounts for 1.89% surprise. Estimated earnings for the next quarter are −0.31 USD. See more details about Applied DNA Sciences, Inc. earnings.
Applied DNA Sciences, Inc. revenue for the last quarter amounts to ‪779.74 K‬ USD despite the estimated figure of ‪1.68 M‬ USD. In the next quarter revenue is expected to reach ‪776.00 K‬ USD.
Yes, you can track Applied DNA Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, APDN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Applied DNA Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
APDN reached its all-time high on Feb 2, 2004 with the price of 8520.00 USD, and its all-time low was 0.37 USD and was reached on Mar 15, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 55.00 employees. See our rating of the largest employees — is Applied DNA Sciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Applied DNA Sciences, Inc. EBITDA is ‪−12.20 M‬ USD, and current EBITDA margin is −71.75%. See more stats in Applied DNA Sciences, Inc. financial statements.